Contact us to request your first appointment.
If you proceed down the Rx Path, youll have your first consultation with a Found provider within 72 hours of filling out the intake form
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
Commonly associated with increased sweating during exercise.
PPARs can be found throughout the body, including in immune and structural cells
P., Hsia S., Eyde S., Liu R., Ma X., Konig M., Kazda C., Mather K